Evidence map›Paper›PMID 20177287›Full record

ArticleObstetrics and gynecology2010

Effect of pregnancy on maternal asthma symptoms and medication use.

Kathleen Belanger, Melissa E Hellenbrand, Theodore R Holford, Michael Bracken

Abstract readMulticenter Study
In one paragraph

Article in Obstetrics and gynecology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Pooled it
  2. Article
  3. Why Every Asthma Patient Tells a Different Story.Journal of clinical medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Treatable Traits in Pregnant Women with Asthma.Respiration; international review of thoracic diseases · 2024
    Review
  9. Asthma in pregnancy.Allergy and asthma proceedings · 2023
    Review
  10. Article
  11. Article
  12. Determining the Clinical Course of Asthma in Pregnancy.The journal of allergy and clinical immunology. In practice · 2022
    Article
  13. The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children.The journal of allergy and clinical immunology. In practice · 2022
    Article
  14. Review
  15. Sex and gender in asthma.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  16. Sex, Cells, and Asthma.Mayo Clinic proceedings · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kathleen BelangerFrom the Center for Perinatal Pediatric and Environmental Epidemiology, Yale University School of Public Health, New Haven, Connecticut.
Melissa E Hellenbrand
Theodore R Holford
Michael Bracken
Yale University · US

Funding

Perinatal Risk of Asthma in Infants of Asthmatic MothersR01AI041040 · NIAID · YALE UNIVERSITY · PI BRACKEN, MICHAEL B · 1996 to 2007
$3.8M
Paraxanthine and Reproductive Effects of CaffeineR01DA005484 · NIDA · YALE UNIVERSITY · PI BRACKEN, MICHAEL B · 1987 to 2004
$684k
NIAID NIH HHS AI41040NIAID NIH HHS R01 AI041040NIDA NIH HHS DA05484NIDA NIH HHS R01 DA005484
6 · The paper itself

Abstract

objectiveTo examine whether factors related to the patient or her treatment influence asthma severity during pregnancy.

methodsSymptom and medication data were collected by in-person and telephone interviews. Women were recruited before 24 weeks of gestation through private obstetricians and hospital clinics. Eight hundred seventy-two women had physician-diagnosed asthma, 686 were active asthmatics, and 641 with complete data were analyzed. The Global Initiative for Asthma measured severity. Cumulative logistic regression models for repeated measures assessed changes in asthma severity during each month of pregnancy.

resultsTwo factors had significant and profound effects on the course of asthma: prepregnancy severity and use of medication according to Global Initiative for Asthma guidelines. Although several factors were analyzed (race, age, atopic status, body mass index, parity, fetal sex, and smoking), none were significant risk factors for changes in asthma severity, measured in a clinically important way as a one-step change in Global Initiative for Asthma category. Women with milder asthma received most benefit from appropriate treatment, 62% decreased risk for worsening asthma among those with intermittent asthma (0.38, 95% confidence interval 0.23-0.64) and 52% decreased risk among those with mild persistent asthma (odds ratio 0.48, 95% confidence interval 0.28-0.84). Month or trimester of gestation was not consistently associated with changes in asthma severity.

conclusionAsthma severity during pregnancy is similar to severity in the year before pregnancy, provided patients continue to use their prescribed medication. If women discontinue medication, even mild asthma is likely to become significantly more severe.

Indexed as

Medication AdherenceAdultAnti-Asthmatic AgentsAsthmaDisease ProgressionFemaleHumansInterviews as TopicPregnancyPregnancy ComplicationsProspective StudiesSeverity of Illness IndexYoung AdultAnti-Asthmatic Agents

Identifiers

PMID20177287
PMCPMC3176497
OpenAlexW1992678389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.